Malignant mixed mullerian tumor: an immunohistochemical study

Area of Science:

• Oncology
• Pathology
• Immunohistochemistry

Background:

• Malignant mixed Mullerian tumors (MMMTs) are rare, aggressive neoplasms with both epithelial and mesenchymal components.
• Accurate diagnosis is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the expression of germ cell markers SALL4, OCT3/4, glypican-3, and alpha-fetal protein (AFP), along with CDX2, in MMMTs.
• To evaluate the utility of these markers in the differential diagnosis of MMMTs.

Main Methods:

• Immunohistochemical staining was performed on a series of MMMT samples.
• Expression levels and patterns of SALL4, OCT3/4, glypican-3, AFP, and CDX2 were analyzed.

Main Results:

• SALL4 showed nuclear immunoreactivity in 33% of cases (6/19), often with intermediate to strong intensity.
• Glypican-3 exhibited cytoplasmic reactivity in 88% of cases (14/16).
• OCT3/4 and AFP expression was limited (1/19 and 2/18 cases, respectively).

Conclusions:

• SALL4 and glypican-3 are frequently expressed in a subset of MMMTs.
• These markers can be valuable in the differential diagnosis of MMMTs.
• Further research is needed to elucidate the roles of SALL4 and glypican-3 in MMMT pathogenesis.